entertainment -WSS

entertainment

author：explore 2025-08-12 08:28:23 - browse：85218

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： EF3 tornado rips through North Carolina amid extreme weather nationwide

WSS

Affordable Connectivity Program vital to health care, experts say

Study identifies new proteins linked to dementia risk 25 years later

Ending racial health disparities hinges on penalties, political will

Texas Department of Public Safety speaks out on migrant abuse allegations

Vir antibody drug aimed at influenza A fails in clinical trial

US soldier in North Korean custody after crossing DMZ line

focus

entertainment

The need-to-know this morning

Is it time to worry about Moderna?

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Duchenne breakthrough therapy leaves behind pioneering families

Mass General totes up its waste in a move to tackle climate change

Psychedelics group wrestles with new pharma identity

A strong 6.5

Duchenne breakthrough therapy leaves behind pioneering families

Biden administration sends mixed signals on US soldier who crossed into North Korea

New air purifier tech could be key to improving indoor air quality

US soldier in North Korean custody after crossing DMZ line

hotspot

Johnson & Johnson sues to stop Medicare negotiation

Mass General totes up its waste in a move to tackle climate change

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Hospitals struggle to profit from CAR

A strong 6.5

House passes resolution saying Israel isn't a 'racist or apartheid state'

entertainment

hotspot

hotspot

hotspot